US2005261377A1PendingUtilityA1
Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
Est. expirySep 3, 2019(expired)· nominal 20-yr term from priority
Inventors:Karl Thor
A61P 43/00A61P 15/00A61P 15/08A61P 15/10A61K 45/06A61K 31/135A61K 31/138
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for the prevention, treatment, or management of sexual dysfunction, such as premature ejaculation, by administering to a patient in need of therapy a therapeutically effective amount of a rapid-onset selective serotonin reuptake inhibitor on an as-needed basis shortly before sexual activity.
Claims
exact text as granted — not AI-modified1 . A method of treating or managing a sexual dysfunction in a mammal in need of treatment comprising administering on an as-needed basis to the mammal an amount of a rapid-onset selective serotonin reuptake inhibitor that is therapeutically effective in the absence of priming dose.
2 . The method of claim 1 , wherein the mammal is a human male.
3 . The method of claim 2 , wherein the sexual dysfunction is selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm.
4 . The method of 3, wherein the sexual dysfunction is retarded ejaculation.
5 . The method of 3, wherein the rapid-onset selective serotonin reuptake inhibitor is administered from about 1 hour to about 8 hours prior to sexual activity.
6 . A method of treating or managing a sexual dysfunction in a mammal in need of treatment comprising administering on an as-needed basis to the mammal an amount of dapoxetine or a pharmaceutically acceptable salt thereof that is therapeutically effective in the absence of a priming dose.
7 . The method of claim 6 , wherein the sexual dysfunction is selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm.
8 . The method of claim 6 , wherein the mammal is a human male.
9 . The method of claim 6 , wherein the sexual dysfunction is retarded ejaculation.
10 . The method of claim 6 , wherein dapoxetine is administered from immediately prior to, to about 12 hours prior to sexual activity.
11 . The method of claim 10 , wherein dapoxetine is administered from immediately prior to, to about 8 hours prior to sexual activity.
12 . The method of claim 10 , wherein dapoxetine is administered from immediately prior to, to about 4 hours prior to sexual activity.
13 . The method of claim 10 , wherein dapoxetine is administered from immediately prior to, to about 3 hours prior to sexual activity.
14 . A method of treating sexual dysfunction selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm in a human male comprising administering orally to the human male about 0.01 mg to about 200 mg of dapoxetine or a pharmaceutically acceptable salt thereof from immediately prior to, to about 4 hours prior to sexual activity.
15 . A method of treating sexual dysfunction selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm in a human male comprising administering orally to the human male about 0.01 mg to about 200 mg of dapoxetine or a pharmaceutically acceptable salt thereof from immediately prior to, to about 3 hours prior to sexual activity.
16 . A method of treating sexual dysfunction selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm in a human male comprising administering orally to the human male about 0.01 mg to about 200 mg of dapoxetine or a pharmaceutically acceptable salt thereof from about 30 minutes to about 3 hours prior to sexual activity.
17 . A method of treating sexual dysfunction selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm in a human male comprising administering orally to the human male about 0.01 mg to about 200 mg of dapoxetine or a pharmaceutically acceptable salt thereof immediately prior to sexual activity.
18 . A method of treating sexual dysfunction selected from the group consisting of retarded ejaculation, low sexual desire, sexual aversion, or inhibited orgasm in a human male comprising administering orally to the human male about 0.01 mg to about 200 mg of dapoxetine or a pharmaceutically acceptable salt thereof immediately prior to sexual activity.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.